Mon Oct 20 16:05:35 SGT 2014  
SEX
CHECKING
    Sex Checking, Timor-Leste
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

Sex Checking, Timor-Leste

Summary

Sex Checking, Timor-Leste @sexchecking_com: Sex symptoms in men/women, screening/diagnosis, testing/check and treatment checking, Timor-Leste - Private and confidential service.

Keywords: Sex Checking Timor-Leste, Timor-Leste Sex Checking, Sex Checking.

Description

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
HIV STD TESTING TREATMENT™
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Sex Checking, Timor-Leste
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Budget airlines based in Singapore:

Budget airlines operating in Singapore:

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute SD Bioline HIV Ag/Ab Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Location reference


Latest News

Sexual risk behaviors in non-injecting substance-dependent Brazilian patients.
Sun, 19 Oct 2014 20:30:03 +0100 | Adicciones
This study seeks to evaluate sexual risk behaviors in non-injecting substance-dependent patients admitted for specialized inpatient Brazilian care. A cross-sectional study using socio-demographic and sexual behavior information, drug of choice, Short Alcohol Dependence Data, Drug Abuse Screening, and Test for Nicotine Dependence was used in 299 subjects with different levels of sexual vulnerability as measured by the number of sexual partners in the last year and the frequency of condom use with intercourse/penetration. The findings showed that approximately 39% the subjects of the high risk sexual behavior group exhibited a higher prevalence of others sexual risk behaviors, including having sex with sex workers (RP=1.96), homosexual experiences, and homosexual experiences in exchange for ...

Understanding Sexually Transmitted Infection Screening and Management in Indiana Community Health Centers
Sat, 18 Oct 2014 05:10:48 +0100 | Sexually Transmitted Diseases
ConclusionsIt is likely that CHCs are not aware of patient sexual health risks because standard of care screening was observed only for gonorrhea and chlamydia during the first trimester and for syphilis testing when symptoms were present. As CHCs increase their role in preventive care with the implementation of the Affordable Care Act, focus must be upon clinician awareness of patient sexual health and training to identify and manage STIs in their patient populations. (Source: Sexually Transmitted Diseases)

Predictors of Index Patient Acceptance of Expedited Partner Therapy for Chlamydia trachomatis Infection and Reasons for Refusal, Sexually Transmitted Disease Clinics, New York City, 2011 to 2012
Sat, 18 Oct 2014 05:10:48 +0100 | Sexually Transmitted Diseases
ConclusionsExpedited partner therapy acceptance rates were high among index patients whose partners were not otherwise treated. (Source: Sexually Transmitted Diseases)

Expedited Partner Therapy for Sexually Transmitted Diseases—Are We There Yet?
Sat, 18 Oct 2014 05:10:48 +0100 | Sexually Transmitted Diseases
No abstract available (Source: Sexually Transmitted Diseases)

For Partner Services, do we need “face-time,” or FaceTime?: Trends in Relative Proportion of In-person Notifications and HIV Testing After Introduction of a Telephone Option for HIV Exposure Notification by Public Health
Sat, 18 Oct 2014 05:10:47 +0100 | Sexually Transmitted Diseases
We examined trends in in-person versus telephone notification for HIV 3 years after the introduction of a telephone option. Most notifications were made by telephone. Partners notified doubled; however, the proportion HIV testing declined slightly. (Source: Sexually Transmitted Diseases)

Y Chromosome and HIV DNA Detection in Vaginal Swabs as Biomarkers of Semen and HIV Exposure in Women
Sat, 18 Oct 2014 05:10:47 +0100 | Sexually Transmitted Diseases
BackgroundThe inability to quantify sexual exposure to HIV limits the power of HIV prevention trials of vaccines, microbicides, and preexposure prophylaxis in women. We investigated the detection of HIV-1 and Y chromosomal (Yc) DNA in vaginal swabs from 83 participants in the HPTN 035 microbicide trial as biomarkers of HIV exposure and unprotected sexual activity.

Vitros 5600 Syphilis TPA Assay: Evaluation of an Automated Chemiluminescence Assay for Detection of Treponema pallidum Antibodies in a High Prevalence Setting
Sat, 18 Oct 2014 05:10:47 +0100 | Sexually Transmitted Diseases
AbstractThe performance of the Syphilis TPA assay (Ortho-Clinical Diagnostics) on Vitros 5600 Integrated System was evaluated and demonstrated excellent results. Our data support the use of this assay for test confirmation in the traditional algorithm and for screening for syphilis in a routine automated laboratory setting when using the reverse algorithm. (Source: Sexually Transmitted Diseases)

The Estimated Impact of Human Papillomavirus Vaccine Coverage on the Lifetime Cervical Cancer Burden Among Girls Currently Aged 12 Years and Younger in the United States
Sat, 18 Oct 2014 05:10:46 +0100 | Sexually Transmitted Diseases
AbstractUsing a previously published dynamic model, we illustrate the potential benefits of human papillomavirus vaccination among girls currently 12 years or younger in the United States. Increasing vaccine coverage of young girls to 80% would avert 53,300 lifetime cervical cancer cases versus 30% coverage and 28,800 cases versus 50% coverage. (Source: Sexually Transmitted Diseases)

The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States
Sat, 18 Oct 2014 05:10:46 +0100 | Sexually Transmitted Diseases
ConclusionsOur results are consistent with estimates in the existing literature suggesting a high lifetime probability of HPV acquisition and are supported by cohort studies showing high cumulative HPV incidence over a relatively short period, such as 3 to 5 years. (Source: Sexually Transmitted Diseases)

Estimating Chlamydia Screening Coverage: A Comparison of Self-report and Health Care Effectiveness Data and Information Set Measures
Sat, 18 Oct 2014 05:10:46 +0100 | Sexually Transmitted Diseases
ConclusionsThe Healthcare Effectiveness Data and Information Set does not accurately identify sexually active women and may underestimate chlamydia testing coverage. Self-reported testing may not be an accurate measure of true chlamydial testing coverage. (Source: Sexually Transmitted Diseases)